• Effective in managing symptoms and improving blood counts.
• Targets abnormal cell growth in the bone marrow.
• Helps in achieving remission of cancerous cells.

Azashine 300 mg tablet binds to RNA and DNA, interrupts their activity in actively multiplying cells, and exhibits a toxic effect on cancer cells. This mechanism is critical in reducing the proliferation of malignant cells and effectively managing blood-related cancers.

Its action emphasizes its efficacy in conditions characterized by rapid cell growth, ensuring controlled disease management and extending patient survival.

Prior to starting Azashine 300 mg Tablet, it is absolutely crucial to inform your doctor about all your current medications. Azashine may interact with these substances, potentially leading to undesirable effects or reduced effectiveness. This step is vital in ensuring the safe and effective use of the medication.

Store the tablets at an ideal temperature of 25°C, away from moisture and direct sunlight. Keep out of reach of children.

Azashine 300mg Tablet Dosages are meticulously tailored based on individual health conditions, body weight, and overall treatment objectives, ensuring that each patient feels confident in the precision and efficacy of their treatment.

To maintain its effectiveness, the tablet should be swallowed whole with water and not altered (crushed, chewed, or broken).

Here are some frequently seen and serious side effects you need to be aware of: 

Common

• Nausea and vomiting are often experienced by many.
• Diarrhea is a frequent digestive system reaction.
• General fatigue is a widespread side effect.
• Headaches and dizziness are common neurological symptoms.
• Stomach pain and constipation are typical gastrointestinal issues.
• Rash and itching are common dermatological reactions.

Serious

• Bruising or bleeding, indicating potential blood disorders.
• Abnormal liver function test results suggest liver issues.
• Swelling of facial areas, a sign of severe allergic reactions.
• Higher risk of catching infections due to a decreased white blood cell count.
• Shortness of breath, which may indicate respiratory problems.
• Anemia, which can lead to significant fatigue and weakness.

Before administering this tablet, it is crucial to notify the doctor of any allergies, respiratory issues, or existing kidney, liver, or heart conditions the patient may have, as well as any other medications being taken, since they may exacerbate the patient's health issues. This medication should not be used if the patient is trying to conceive, is pregnant, or is breastfeeding due to its potentially harmful effects on the developing baby. This tablet should be taken strictly under medical supervision, with dosages tailored by the doctor according to the patient’s height, weight, and overall health condition. 

1. K. Gaston and P.-S. Jayaraman, Transcriptional repression in eukaryotes: Repressors and repression mechanisms, Cellular and Molecular Life Sciences, [May 2003], 60(4):721-741, [Accessed on 5th Apr 2021] https://www.researchgate.net/publication/7094896_Transcriptional_repression_in_eukaryotes_Repressors_and_repression_mechanisms
2. Roman M. Shapiro & Alejandro Lazo-Langner, Systematic review of azacitidine regimens in myelodysplastic syndrome and acute myeloid leukemia, BMC Hematology, 2018 [Accessed on 3rd Apr 2021] https://bmchematol.biomedcentral.com/articles/10.1186/s12878-017-0094-8
3. Dr.Reddy’s Laboratories, [Revised on 8th Nov 2018] [Accessed on 5th Apr 2021] https://www.drreddys.com/media/743001/ac-pm-english.pdf